Chi-Sheng Shia Selected Research

GalNAc- 1- 3- (Fuc- 1- 2)Gal- 1- 3- GlcNAc- 1- 3- Gal- 1- 4- Glc- PA

1/2021

Preclinical Studies of OBI-999: A Novel Globo H-Targeting Antibody-Drug Conjugate.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Chi-Sheng Shia Research Topics

Disease

4	Hemolysis 01/2011 - 01/2009
2	Neoplasms (Cancer) 01/2021 - 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2016

Drug/Important Bio-Agent (IBA)

3	2,2'-azobis(2-amidinopropane) (ABAP)IBA 01/2011 - 01/2009
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2019
2	ProdrugsIBA 01/2021 - 01/2019
1	GalNAc- 1- 3- (Fuc- 1- 2)Gal- 1- 3- GlcNAc- 1- 3- Gal- 1- 4- Glc- PAIBA 01/2021
1	Globo-HIBA 01/2021
1	nelarabine (506U78)FDA Link 01/2019
1	Messenger RNA (mRNA)IBA 01/2019
1	Multidrug Resistance-Associated ProteinsIBA 01/2016
1	Multidrug Resistance-Associated Protein 2IBA 01/2016
1	Methotrexate (Mexate)FDA LinkGeneric 01/2016
1	PolyphenolsIBA 01/2016
1	Immunosuppressive Agents (Immunosuppressants)IBA 01/2016
1	Proteins (Proteins, Gene)FDA Link 01/2016
1	AntioxidantsIBA 01/2011
1	Emodin (Archin)IBA 04/2010
1	Free RadicalsIBA 10/2009
1	AnthraquinonesIBA 10/2009
1	fisetinIBA 01/2009

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2021
1	Aftercare (After-Treatment) 01/2021
1	Castration 01/2021
1	Immunotherapy 01/2021
1	Therapeutics 01/2021
1	Oral Administration 04/2010